Why SwiftDetect is right for pharmaceutical companies

28 February 2020

SwiftDetect is a super-sensitive hybrid quantitative polymerase chain reaction (qPCR) test that can detect down to a single microbiological cell in any sample volume, yielding results in under six hours.

SwiftDetect is 56 times faster than conventional testing methods like direct inoculation and membrane filtering for analysis of samples. This eliminates the need for traditional microbiological culturing methods, saving you money and time as well as being GLP and GMP compliant.

Within 1 business day of receiving your samples, your results will be available. Using SwiftDetect on pharmaceuticals means on-time batch release so that verification of safety and sterility is assured on dispatch.

SwiftDetect uses a patented quantitative polymerase chain reaction (PCR) style of rapid test, adapted by our team for enhanced sensitivity. We can therefore detect contamination comprising of a single cell in only 6 hours, revolutionising the way we perform microbiological testing.

Our scientists are trained in correct handling procedures and aseptic techniques and process your samples in our state of the art lab designed specifically for SwiftDetect testing.

If you’re interested in talking to us about SwiftDetect and how your organisation might benefit from it, get in touch today.